NICE’s guidance will help health and social care professionals “negotiate complex legislation and regulations to ensure they are doing all they can to care for patients being treated with controlled drugs”, says the body.
The recommendations emphasise that:
Dr Tessa Lewis, GP and chair of the guideline development group, said: "A great deal of work has been done recently to help ensure the safe use and management of controlled drugs at a local and national level. However, ongoing activity and vigilance is required to sustain the positive developments that have been achieved since the changes to the structure of the NHS took effect in 2012."
"Robust systems and processes must be in place for this group of medicines, said NICE. “In considering changes to legislation and to the NHS structure as well as relevant patient safety incidents, this guidance provides further clarity and good practice recommendations across most NHS settings and people’s own homes."
The guidance applies to all NHS settings except care homes: www.nice.org.uk/guidance/ng46